A Method To Enable Normal Lymphocytes To Recognize And Destroy Melanoma Tumor Cells Expressing The MART-1 Tumor Antigen
Technology
E-106-2004
Patent ID
E-106-2004-0-US-02
Country
US
Application Type
National Stage
Patent Status
Abandoned
Patent Number
7915036
Publication Number
US2009-0053184
Application Number
11/575,077
IC
NCI
Date Filed
Date Issued